supplement industry

Kobayashi Pharmaceutical, the Japanese maker at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer worth more than ¥500 billion. The move would mark a major development for a company whose reputation and finances were badly damaged by the scandal, and market watchers are closely following what a takeover could mean for its future.

Al Jazeera reports that the booming longevity industry — anti-ageing treatments, supplements and clinics promising longer, healthier lives — is outpacing the scientific evidence behind many of its claims. The piece suggests consumers are spending on interventions whose long-term benefits and risks remain largely unproven, raising concerns about hype, regulation and safety as the market grows.

New market analysis projects the global dietary supplements industry will grow to $324.9 billion by 2034. The forecast points to sustained demand for vitamins, minerals and other nutraceutical products as consumers worldwide increasingly focus on preventive health and everyday nutrition. Industry observers expect the finding to draw attention from supplement makers, retailers and investors tracking the sector's long-term expansion.

A new market forecast projects steady growth in the global dietary supplements industry through 2035, with personalized nutrition and gut health products cited as the main drivers. Analysts point to rising consumer interest in tailored vitamins, probiotics and microbiome-focused formulations as manufacturers expand offerings. Industry observers say the wellness trend and growing health awareness are reshaping demand across major markets.